Mei Li Chang

Quick links

Choose a section

Quick links to important sections

Advertisements

Mei Li Chang

Advertisements
Advertisements
Advertisements

Overview of Mei Li Chang

What is Mei Li Chang? The Identity and Purpose of Terazosin

The drug Mei Li Chang is a pharmaceutical product defined by its specific chemical structure and its targeted action on the body's involuntary muscle systems. As a single-active-ingredient, prescription-only medication, it is utilized for managing chronic conditions associated with smooth muscle tone.

Property Description
Active Ingredient Terazosin hydrochloride
Form Oral Capsule or Tablet
Pharmacological Class Alpha-adrenergic blocking agent (alpha1-blocker)
Common Use Reducing muscle tone in blood vessels and the lower urinary tract
Origin Synthetic quinazoline derivative

What is the Active Substance and Pharmacological Class of Mei Li Chang?

The active ingredient in Mei Li Chang is Terazosin hydrochloride. This compound is classified as an alpha-adrenergic blocking agent, or alpha-blocker, distinguishing it from beta-blockers or calcium channel blockers. Terazosin is a synthetic quinazoline derivative that has been engineered to interact precisely with alpha-1 adrenergic receptors. Its core differentiating feature is its established long-acting duration of effect, which often supports a once-daily dosing regimen.

How Does This Type of Medication Generally Affect the Body?

The core function of this medication relates to the selective blockade of alpha-1 adrenergic receptors distributed throughout the body. By inhibiting these receptors, Mei Li Chang facilitates smooth muscle relaxation in specific tissues, including the peripheral blood vessel walls and the muscular components of the prostate gland and bladder neck. This pharmacological action contributes to the drug's general therapeutic utility by alleviating the physical tension and resistance that can constrict these structures. The resulting vasodilation and reduced internal resistance promote generalized smoother flow within the systems targeted.

In What Form is Mei Li Chang Typically Provided?

Mei Li Chang is typically provided in a form suitable for oral administration, such as an oral capsule or tablet. These preparations contain the active Terazosin hydrochloride ingredient alongside necessary pharmaceutical excipients. The oral route is designed for systemic absorption, allowing the drug to reach and modulate alpha receptors throughout the body, providing a continuous, long-acting effect. The drug is notable within its class for its established ability to address vascular tone and lower urinary tract resistance simultaneously.

Advertisements

What side effects are possible with Mei Li Chang?

Possible side effects and safety information

The safety profile of Mei Li Chang (terazosin) is based on official classifications found in regulatory documents, with adverse reactions generally grouped by the system-organ class affected and categorized by frequency.

Frequency-Classified Adverse Reactions

The most frequently documented effects relate to the vascular and nervous systems. In regulatory terms, Very Common reactions (affecting ge 10% of users) include dizziness, headache, and asthenia (lack of energy). Common reactions (affecting ge 1% to < 10% of users) include orthostatic hypotension (dizziness upon standing), somnolence (drowsiness), palpitations, and peripheral edema (swelling).

Time-Related Safety Pattern

The official labeling notes a Time-Related Onset Pattern where the risk of dizziness and orthostatic hypotension is highest immediately after the initial dose or following a dose increase (known as the First-Dose Phenomenon).

Serious Adverse Reactions and Constraints

Syncope (fainting) is documented as an Uncommon but serious adverse reaction. Post-marketing surveillance has identified Priapism (a painful, prolonged erection) and Intraoperative Floppy Iris Syndrome (IFIS), which may occur during cataract surgery, as serious events. The medication is officially contraindicated in individuals with a known hypersensitivity to quinazoline derivatives, and its use in the pediatric population is not established in official documents.

Population-Specific Safety Notes

Specific caution is warranted for patients with hepatic impairment, as use in severe hepatic impairment is not recommended. Furthermore, concomitant use with other antihypertensive agents or PDE-5 inhibitors may result in additive hypotensive effects (low blood pressure), a key high-level safety consideration documented in the labeling.

Advertisements

Overdose and Emergency Response

The official regulatory profile for a potential overdose of Mei Li Chang (Terazosin) is defined by the exaggeration of its core pharmacological effects, which primarily affects the body's circulation and blood pressure regulation.

System Documented Overdose Signs/Symptoms
Circulatory Profound hypotension (abnormally low blood pressure)
Neurological Extreme dizziness, lightheadedness, fainting (syncope), and blurred vision

Overdose may lead to severe, life-threatening outcomes, including hemodynamic instability, collapse, seizures, trouble breathing, or the inability to be awakened. In all suspected cases of overdose, official prescribing information mandates that individuals seek immediate medical attention.

If severe, life-threatening symptoms are present, individuals must immediately call emergency services and contact a poison control center. Regulatory documents describe the management of overdose as symptomatic and supportive treatment. There are no specific antidotes known for the drug’s toxicity.

Initial procedures include placing the patient in a recumbent position (lying down) to help stabilize blood pressure. Further management may involve the use of vasopressors to support physiologic blood pressure parameters, especially if severe hypotension is present. Continued monitoring of vital signs is necessary to manage potential complications and support the patient's stability.

Advertisements

Therapeutic Uses of Mei Li Chang

What Mei Li Chang Treats: Main Uses and Benefits

Easing Physical Heaviness and Stiffness

The traditional therapeutic areas relevant to this medicine may be part of symptomatic management. This medicine is generally used in situations involving certain distressing symptoms across three core domains: easing feelings of physical heaviness and stiffness, supporting digestive comfort, and managing generalized tiredness.

This supportive remedy is relevant for easing symptom clusters related to physical discomfort, such as body aches and stiffness, and systemic imbalance, including poor appetite and lethargy. It may assist with maintaining functional stability by supporting patients in coping more steadily with symptom fluctuations.

Quick Fact: Relevant for easing symptoms related to systemic imbalance

This medicine is commonly used when symptoms create noticeable physiological strain, making everyday activities feel weighed down.

Supporting Comfort and Function

Mei Li Chang is commonly used to help with symptoms related to digestive discomfort, such as abdominal bloating, feeling of fullness, or loose, sticky stools. When symptoms intensify and supportive relief is needed, this medicine can contribute to improved comfort during symptomatic periods and assists with maintaining functional stability.

Regulatory References

  1. Therapeutic Goods Administration of Australia (TGA) register
Advertisements

Eligibility and Restrictions for Use

Eligibility for Mei Li Chang (Terazosin): Official Regulatory Summary

Mei Li Chang (Terazosin) is officially indicated for use in adults (18 years and older) for both the treatment of Benign Prostatic Hyperplasia (BPH) symptoms and the management of Hypertension.

Populations for Whom Use is Prohibited or Restricted

Classification Status and Context
Absolute Contraindications Prohibited in patients with a known hypersensitivity to terazosin or other related quinazoline-derivative alpha-blockers.
Age-Group Exclusion Not established or Not recommended for the pediatric population (under 18 years), as safety and efficacy data are insufficient.
Pregnancy/Lactation Restricted. Safety during pregnancy is not established, and use is only considered if the potential benefit outweighs the risk. It is unknown if the drug is excreted in breast milk.
Conditional Use Caution is advised in patients with existing hepatic dysfunction. Prior to starting therapy for BPH, prescribers must rule out the presence of prostatic carcinoma. Patients planning cataract surgery should inform their ophthalmologist.

Older adults should use the medicine with caution due to an increased risk of specific effects, and use for hypertension is often considered less favorable than alternatives. Contraindications also apply to patients with a history of micturition syncope or certain advanced conditions like anuria or bladder overflow.

Advertisements

What should I know about interactions with other medicines?

The official regulatory profile for Mei Li Chang details interactions that can alter systemic exposure or modify blood pressure effects. Pharmacodynamic interactions carry the primary risk, as co-administration with other Antihypertensive Agents (such as diuretics or beta-blockers) and PDE5 Inhibitors can result in documented additive blood pressure lowering effects. Conversely, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are noted to reduce the antihypertensive efficacy of this medicine through pharmacodynamic antagonism.

Formal regulatory prohibitions exist for specific substances. Vardenafil and the herbal product Yohimbe are officially classified as contraindicated combinations due to the high risk of severe hypotension resulting from documented pharmacodynamic synergism.

Pharmacokinetic interactions documented in the prescribing information show that co-administration with agents like Verapamil is known to increase the systemic exposure of Mei Li Chang. A population-specific caution advises that use requires careful consideration in patients with impaired hepatic function, as the regulatory profile indicates a potential for drug accumulation. A specific timing-based restriction applies to PDE5 inhibitors; administration of Sildenafil at doses greater than 25, mg requires a mandatory four-hour separation interval. The regulatory profile also notes that alcohol consumption may heighten the risk of certain hypotensive symptoms.

Advertisements

Mechanism of Action

alpha1-Receptor Blockade: Interruption of Smooth Muscle Contraction

The action of the drug begins with the competitive blockade of alpha1-adrenergic receptors, which are crucial checkpoints for signals that promote smooth muscle tension. This interference suppresses the binding of the neurotransmitter Norepinephrine, interrupting the cascade that promotes the contraction of muscle cells in blood vessel walls and the urinary tract. By modifying this early molecular step, the drug initiates a sequence that reduces the intracellular signaling required for muscle contraction in the affected systems.


Dual Mechanism for Modulating Resistance and Pressure

The alpha1-blockade mechanism produces two primary physiological consequences based on its action in distinct anatomical locations. In the vascular system, the relaxation of the smooth muscle in arterioles produces systemic vasodilation and a decrease in mechanical resistance. Concurrently, the relaxation of the smooth muscle surrounding the prostate and bladder neck results in decreased pressure on the urethra. This combined physiological modulation of resistance and pressure represents the primary consequence of the drug’s mechanism.


Mechanistic Constraints and Non-Dynamic Factors

The primary mechanism is limited to addressing the dynamic component—the tension or tone—of the smooth muscle. The mechanism does not effectively target the static component, which is the fixed resistance caused by physical tissue mass or structural enlargement. This constraint means the physiological adjustment is focused solely on reducing muscle tone, and not on reversing or reducing non-muscular structural changes within the affected tissues.

Advertisements

Dosage and Administration Information

Administration Guidelines for Mei Li Chang

The use of Mei Li Chang (terazosin) is governed by specific, structured protocols designed for oral administration. The medicine is provided in oral forms, such as a capsule or tablet, intended for systemic action through the oral route.

Official Dosing and Titration

The administration protocol mandates a stepwise titration to establish the appropriate long-term dose. Treatment must begin with the lowest available strength, 1 mg, administered once daily. Following the official guidelines, the dose is gradually increased over time to 2 mg, 5 mg, and then typically to a maintenance range of 5 mg to 10 mg once daily. The highest daily dose officially sanctioned for use in adults is 20 mg.

Timing and Context

A crucial procedural requirement is the timing of the initial dose and any subsequent dose increase: both must be administered at bedtime. This medication may be taken with or without food as intake conditions do not significantly alter its absorption. Although once-daily dosing is standard, twice-daily administration may be considered for the management of high blood pressure if the effect diminishes over 24 hours.

Procedural Rules

Official instructions also address treatment interruptions. If the course of the medicine is stopped for several days or longer, the protocol requires that the therapy be reinitiated using the starting dose of 1 mg to ensure adherence to the labeled protocol. While no specific dose is established for pediatric patients, dose adjustments are often advised for older adults to reflect changes in drug clearance. The 1 mg strength is the only dose approved for initiating therapy.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Mei Li Chang

The research evidence for Mei Li Chang focuses on its use relevant to symptoms related to prostate enlargement (Benign Prostatic Hyperplasia or BPH) and in the context of research for high blood pressure (Hypertension). Evidence for both uses is primarily derived from highly controlled clinical trials, which help contextualize how patients reported their experience during the study period.


Evidence for Use in Benign Prostatic Hyperplasia (BPH)

Studies conducted to explore the effects of Mei Li Chang in conditions characterized by functional limitations related to BPH symptoms primarily involve Randomized Controlled Trials (RCTs). These short-term (lasting 8 to 12 weeks) and longer-term trials were applied in studies examining patient-reported experiences in adult males with symptomatic BPH. Researchers monitored outcomes related to functional imbalance, specifically looking at the change in patient-reported urinary symptom scores and objective measurements of urinary flow rate.

Studies reported measurements of changes in urinary symptom scores and flow rates, with observations recorded within the first 8 weeks of study. Further long-term studies, some extending beyond three years, described the observation of these measured outcomes over an extended period. Research examined the average change in measured PFR and symptom scores across multiple trials.


Evidence for Use in High Blood Pressure (Hypertension)

Research has explored the use of Mei Li Chang in studies examining symptom intensity or variability related to elevated blood pressure. The evidence base includes Randomized Controlled Trials (RCTs) and long-term observational studies, some spanning up to two years. Research monitored changes in standing and supine Blood Pressure (BP) in millimeters of mercury (mmHg). These studies were evaluated in adult patient cohorts with mild to moderate essential hypertension.

Data show patterns related to how blood pressure measurements changed over the study period, including measurements taken both shortly after administration (peak effect) and at the end of the dosing interval (trough effect). Measured changes in blood pressure were reported to be proportional to the patient’s initial blood pressure levels.


What Research Still Needs to Explore

Findings describe patterns observed in the studies, but there remain several key limitations and evidence gaps. Long-term effects are not well characterized regarding the potential for the medicine to alter the structural progression of BPH or the avoidance of related surgery. Additionally, follow-up durations were limited in the initial studies. Research does not determine whether an individual may respond similarly to the study results, which reflect the specific conditions under which they were conducted. More data are still emerging, and research is ongoing to fully characterize the long-term impact on various clinical outcomes.

Key Studies & References

  1. Terazosin - StatPearls (NIH National Library of Medicine)
  2. Terazosin in the Treatment of Hypertension and Symptomatic Benign Prostatic Hyperplasia: A Primary Care Trial
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Mei Li Chang (FAQ)


Q: Is Mei Li Chang a brand name or a generic name?

The active ingredient in the medicine is terazosin hydrochloride, which is the generic name for the drug. Mei Li Chang is a trade name for a product that contains this active ingredient, similar to other previously marketed names.


Q: What should I do if the side effects of Mei Li Chang don't go away after a week?

Regulatory guidelines and patient information advise contacting a healthcare provider if side effects are bothersome, persistent, or cause you concern. This allows for an assessment of the situation based on your specific health profile.


Q: Does Mei Li Chang cause long-term side effects that I should be aware of?

Clinical trials often focus on short- to medium-term data, but the drug is associated with long-term adverse events identified through post-marketing surveillance, such as Priapism (a prolonged erection) and Intraoperative Floppy Iris Syndrome (IFIS). Safety monitoring is continuous to identify and document these events over time.


Q: Can you take Mei Li Chang with common pain relievers like ibuprofen or acetaminophen?

Official labeling notes that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, may reduce the blood pressure-lowering effects of the medicine. There are typically no specific warnings about acetaminophen (paracetamol) in the general regulatory documentation. It is important to discuss all medications with a healthcare provider before combining them.


Q: Does Mei Li Chang interact with any common vitamins or herbal supplements?

The herbal supplement Yohimbe is explicitly contraindicated (prohibited) due to the risk of severe hypotension (very low blood pressure). Regulatory information advises consulting with a healthcare professional regarding all supplements, including herbal products and vitamins, to ensure there are no unintended effects.


Q: Is it safe to drink alcohol in moderation while taking Mei Li Chang?

Official labeling states that consuming alcohol may increase the risk of hypotensive symptoms, such as dizziness and lightheadedness. The regulatory profile suggests using caution when consuming alcohol due to the increased risk of these symptoms.


Q: What types of foods or drinks are known to interact with Mei Li Chang?

The medicine can be taken with or without food, as intake conditions do not significantly alter its absorption. Alcohol is noted to increase the risk of certain side effects. Regulatory documents do not typically list other specific food interactions to avoid.


Q: How long does it usually take to notice the benefits of Mei Li Chang?

In clinical trials supporting the use of the drug for BPH symptoms, measurable changes in urinary symptom scores and flow rates were observed within the first 8 weeks of starting therapy. The patient-reported experience of noticeable benefits can vary.


Q: If I stop taking Mei Li Chang, do the effects wear off immediately?

The drug is classified as long-acting, with an approximate half-life of 12 hours. This suggests that the medication is cleared from the body gradually, not immediately, and its effects diminish over time as the concentration decreases.


Q: What is the typical duration of treatment with Mei Li Chang?

Mei Li Chang is indicated for chronic conditions such as BPH and hypertension. Clinical studies supporting its use have observed patient outcomes over both short-term periods (8–12 weeks) and long-term periods extending over multiple years.


Q: Does Mei Li Chang build up in your system over time?

Official documents note that clearance of the drug may be reduced in patients with impaired hepatic function (liver problems). In this specific population, there is a potential for drug accumulation. Official guidelines recommend that any liver concerns be discussed with a healthcare provider.


Q: Is Mei Li Chang considered a controlled substance?

No, the active ingredient, Terazosin, is classified as a prescription-only medication but is not listed as a federally controlled substance by the U.S. Drug Enforcement Administration (DEA) or other regulatory bodies.


Q: Can people with kidney problems or liver issues use Mei Li Chang?

Caution is advised for patients with hepatic impairment (liver issues), and use in severe liver impairment is not recommended. The regulatory profile does not indicate a need for dose adjustment specifically due to renal impairment (kidney problems).


Q: Does Mei Li Chang have a risk of dependence or addiction?

The drug's official regulatory labeling does not list abuse, tolerance, or dependence as known complications or risks associated with its use.


Q: Is Mei Li Chang used 'as needed' or taken every day?

Mei Li Chang is prescribed as a treatment for chronic conditions and is typically taken once daily according to the established administration protocol, not on an 'as-needed' basis.


Q: If Mei Li Chang is taken by mouth, can the pill be crushed or split?

The drug is provided as a capsule which is intended to be swallowed whole. Regulatory guidance does not include instructions for crushing, splitting, or otherwise altering the contents or physical form of the oral preparation.


Q: Is it true that Mei Li Chang is less effective when taken with dairy products?

The official administration protocol states that the medicine may be taken with or without food. There are no specific warnings or guidance in the regulatory documents about avoiding dairy products.


Q: Does Mei Li Chang affect your ability to drive or operate machinery?

Official warnings advise that side effects like dizziness and drowsiness may affect the ability to drive or operate machinery. Caution is generally indicated, particularly after the first dose or a dose increase.


Q: Can Mei Li Chang be taken with birth control pills?

The regulatory product information does not list any specific known interactions between the active ingredient and oral contraceptive medications.


Q: What happens if Mei Li Chang is taken in combination with caffeine?

While there is no documented drug-to-drug interaction with caffeine, some general health guidance related to BPH symptoms suggests that reducing caffeine intake may be helpful. Consultation with a healthcare provider is recommended for guidance regarding caffeine consumption.


Q: Is it required to get blood tests while taking Mei Li Chang?

The prescribing information recommends periodic monitoring of certain laboratory parameters. This may include tests such as a Complete Blood Count (CBC) and Liver Function Tests (LFTs).


Q: Do health conditions like high blood pressure or diabetes affect who can use Mei Li Chang?

The drug is indicated (officially used) for the management of high blood pressure. There are no specific warnings or contraindications related to diabetes listed in the regulatory documents.


Q: Can I take Mei Li Chang if I am also taking an antidepressant or anti-anxiety medicine?

Mei Li Chang can cause central nervous system effects such as dizziness and drowsiness. These effects may be intensified when taken alongside other medicines that also affect the central nervous system, which includes some antidepressants or anti-anxiety drugs.


Q: What is the half-life of Mei Li Chang (how long does it stay in the body)?

The approximate plasma elimination half-life of the active ingredient is 12 hours. The half-life describes the time it takes for half of the drug to be cleared from the bloodstream.


Q: Does Mei Li Chang interact with herbal remedies like St. John's Wort or Ginkgo?

The herbal product Yohimbe is contraindicated (prohibited). Regulatory documents do not list specific interactions with St. John's Wort or Ginkgo but generally advise caution with all herbal remedies due to the potential for unknown interactions.


Q: Does Mei Li Chang interact with cold and flu medications?

Cold and flu medications often contain ingredients, such as decongestants or pain relievers, that can affect blood pressure or increase the risk of drowsiness. Regulatory information advises caution when combining the drug with any over-the-counter medications.


Q: How is the safety of Mei Li Chang monitored after it has been approved?

Safety is continuously monitored through post-marketing surveillance. This is a system where healthcare professionals report adverse events, allowing regulators to identify and document reactions, such as Priapism or IFIS, that may not have been seen during initial clinical trials.


Q: Why do some people experience initial side effects that later disappear?

The risk of side effects, particularly dizziness and orthostatic hypotension (a drop in blood pressure when standing), is highest after the first dose. This is known as the First-Dose Phenomenon. Official patient information suggests that these effects often become less noticeable after taking several doses.


Q: What happens if I miss a dose of Mei Li Chang?

Regulatory instructions advise that if a regular dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely to avoid taking too much medicine at once.


Q: Is Mei Li Chang approved by the FDA or other similar global bodies?

The active ingredient, Terazosin, is approved for use by the U.S. Food and Drug Administration (FDA) and is registered by other global regulatory bodies for its indicated uses.


Q: What is the difference between the active ingredient in Mei Li Chang and the inactive ingredients?

The active ingredient (terazosin hydrochloride) is the component that produces the intended pharmacological effect in the body. Inactive ingredients (or excipients) are necessary substances used to form the capsule or tablet and ensure the medication's stability and proper delivery.


Q: Can I take Mei Li Chang if I have a history of heart problems?

The medicine affects the vascular system and can cause side effects like palpitations (pounding heart) and dizziness upon standing. While there are no broad contraindications for all heart problems, patients with a history of micturition syncope (fainting during urination) or other specific conditions require careful assessment before use.


Q: How common are serious side effects from Mei Li Chang in the general population?

The official labeling provides frequency estimates for certain serious reactions. For example, syncope (fainting) is documented as an Uncommon adverse reaction, meaning it affects less than 1% of users. Other serious events like Priapism and IFIS are reported via post-marketing surveillance.


Q: Is it normal to feel [mild, non-serious symptom like dry mouth or drowsiness] when starting Mei Li Chang?

The official side effect profile lists somnolence (drowsiness) as a Common reaction, meaning it affects 1% to <10% of users. The risk of dizziness is also highest when starting the medicine. Official documentation does not typically include dry mouth among the most frequently reported adverse reactions.

Advertisements

How should Mei Li Chang be stored and disposed of?

The storage and disposal of Mei Li Chang (Terazosin) must adhere strictly to the conditions specified in official regulatory labeling to maintain product integrity and ensure safety.

Official Storage Requirements

Condition Requirement (Official Labeled Instructions)
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep in the original, tightly closed container and protect from excessive moisture and humidity.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired product should be disposed of through a medicine take-back program whenever one is available. If a take-back option is not readily accessible, the medication should be mixed with an unappealing substance, placed in a sealed bag or container, and discarded with household trash. Regulatory guidance prohibits flushing this medication down the toilet or pouring it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mei Li Chang found in:

A-Z Index: